Research
Energy balance
Weight loss interventions, including bariatric surgery, specific diets (Mediterranean, Low-Carbohydrate, VLCKD), and GLP-1 receptor agonists (Liraglutide, Semaglutide, Dulaglutide, Tirzepatide), improve renal outcomes by reducing albuminuria and improving eGFR.
If you have obesity and kidney concerns, weight loss is critical. Bariatric surgery, GLP-1 medications (like Semaglutide or Tirzepatide), and structured diets (Mediterranean or Low-Carb) can significantly reduce kidney damage risk. Consult a doctor before starting VLCKD if you have existing kidney disease.
GoodSupportsHIGH confidence
In subjects with obesity, weight loss can slow down the progression of renal failure with a significant reduction in proteinuria and improvement in glomerular filtratation rate. Specifically, in the management of subjects with obesity and renal disease, it has been shown that bariatric surgery can prevent the decline in renal function...
Why this rating
Supported by multiple RCTs (DIRECT, LEADER, SUSTAIN 6, REWIND) and observational studies.
Source
The Fat Kidney
Ludovica Verde et al. · Current Obesity Reports · 2023
DOI 10.1007/s13679-023-00500-9
narrative_reviewCited 21×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →